
Levodropropizine NEW
Price | $29 |
Package | 1mL |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-04-27 |
Product Details
Product Name: Levodropropizine | CAS No.: 99291-25-5 |
Purity: 99.93% | Supply Ability: 10g |
Release date: 2025/04/27 |
Product Introduction
Bioactivity
Name | Levodropropizine |
Description | Levodropropizine ((S)-(-)-Dropropizine) is a histamine receptor inhibitor. It is used as an effective and very well tolerated peripheral antitussive drug. |
In vitro | Research indicates that Levodropropizine effectively suppresses cough in anesthetized guinea pigs and rabbits. Intravenous administration of Levodropizine in these animals, during mechanically and electrically induced coughs, shows an activity ranging from one-tenth to one-twentieth of codeine, similar to hydroxyzine. Oral Levodropizine treatment for cough induced by irritant aerosols has effects comparable to hydroxyzine and codeine. An intravenous dose of 15 mg/kg Levodropropizine reduces the duration of asphyxiation and the C-fiber response to phenylbiguanide. Additionally, Levodropropizine dose-dependently decreases capsaicin-induced Evans blue dye extravasation in rat airways. |
In vivo | Levodropropizine exhibits affinity for both H1 histamine and α-adrenergic receptors. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | Ethanol : 44 mg/mL (186.2 mM), Sonication is recommended. H2O : 12 mg/mL (50.78 mM), Sonication is recommended. DMSO : 55 mg/mL (232.75 mM), Sonication is recommended. |
Keywords | Levodropropizine | Inhibitor | inhibit | HT | HistamineReceptor | Histamine Receptor | Dropropizine | DF526 | DF 526 | 5HTReceptor | 5HT Receptor |
Inhibitors Related | Alverine citrate | Meclizine dihydrochloride | Dapoxetine hydrochloride | Clozapine N-Oxide | Lidocaine | Famotidine | Sodium butanoate | D-Menthol | Alginic acid | Trazodone hydrochloride | Mianserin hydrochloride | Cinchonidine |
Related Compound Libraries | Pain-Related Compound Library | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$29.00/1mL |
VIP1Y
|
TargetMol Chemicals Inc.
|
2025-04-29 | |
$29.00/1mL |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-04-28 | |
$0.00/1kg |
VIP1Y
|
Hebei Junhua Import and Export Co., LTD
|
2025-03-31 | |
$0.00/1kg |
VIP4Y
|
Wuhan Biocar Pharmacy CO.,Ltd.
|
2025-03-05 | |
$1.00/1kg |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-13 | |
$15.00/1kg |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-24 | ||
$200.00/1kg |
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-04-24 | ||
$0.00/25kg |
PNP Biotech Co. Ltd
|
2022-10-20 | ||
$10.00/1kg |
Hebei Linwo New Material Technology Co., LTD
|
2022-06-30 | ||
$50.00/1KG |
VIP5Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2022-06-29 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY